{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T22:49:15Z","timestamp":1761518955742},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2009,10,8]],"date-time":"2009-10-08T00:00:00Z","timestamp":1254960000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Breast Cancer"],"published-print":{"date-parts":[[2011,4]]},"DOI":"10.1007\/s12282-009-0175-z","type":"journal-article","created":{"date-parts":[[2009,10,7]],"date-time":"2009-10-07T04:12:56Z","timestamp":1254888776000},"page":"120-123","source":"Crossref","is-referenced-by-count":9,"title":["Low incidence of methylation of the promoter region of the FANCF gene in Japanese primary breast cancer"],"prefix":"10.1007","volume":"18","author":[{"given":"Eriko","family":"Tokunaga","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoko","family":"Okada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Kitao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoko","family":"Shiotani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Saeki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuya","family":"Endo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaru","family":"Morita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihiro","family":"Kakeji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihiko","family":"Maehara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,10,8]]},"reference":[{"key":"175_CR1","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S1470-2045(07)70074-8","volume":"8","author":"S Cleator","year":"2007","unstructured":"Cleator S, Heller W, Coombes RC. Triple-negative breast cancer: therapeutic options. Lancet Oncol. 2007;8:235\u201344.","journal-title":"Lancet Oncol"},{"key":"175_CR2","doi-asserted-by":"crossref","first-page":"10869","DOI":"10.1073\/pnas.191367098","volume":"98","author":"T Sorlie","year":"2001","unstructured":"Sorlie T, Perou CM, Tibshirani R, Aas T, Geisler S, Johnsen H, et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci USA. 2001;98:10869\u201374.","journal-title":"Proc Natl Acad Sci USA"},{"key":"175_CR3","doi-asserted-by":"crossref","first-page":"8418","DOI":"10.1073\/pnas.0932692100","volume":"100","author":"T Sorlie","year":"2003","unstructured":"Sorlie T, Tibshirani R, Parker J, Hastie T, Marron JS, Nobel A, et al. Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc Natl Acad Sci USA. 2003;100:8418\u201323.","journal-title":"Proc Natl Acad Sci USA"},{"key":"175_CR4","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1038\/nrc1457","volume":"4","author":"N Turner","year":"2004","unstructured":"Turner N, Tutt A, Ashworth A. Hallmarks of \u2018BRCAness\u2019 in sporadic cancers. Nat Rev Cancer. 2004;4:814\u20139.","journal-title":"Nat Rev Cancer"},{"key":"175_CR5","doi-asserted-by":"crossref","first-page":"5846","DOI":"10.1038\/sj.onc.1209876","volume":"25","author":"NC Turner","year":"2006","unstructured":"Turner NC, Reis-Filho JS. Basal-like breast cancer and the BRCA1 phenotype. Oncogene. 2006;25:5846\u201353.","journal-title":"Oncogene"},{"key":"175_CR6","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/nature03445","volume":"434","author":"H Farmer","year":"2005","unstructured":"Farmer H, McCabe N, Lord CJ, Tutt AN, Johnson DA, Richardson TB, et al. Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy. Nature. 2005;434:917\u201321.","journal-title":"Nature"},{"key":"175_CR7","doi-asserted-by":"crossref","first-page":"2568","DOI":"10.1200\/JCO.2007.13.1748","volume":"26","author":"EA Rakha","year":"2008","unstructured":"Rakha EA, Reis-Filho JS, Ellis IO. Basal-like breast cancer: a critical review. J Clin Oncol. 2008;26:2568\u201381.","journal-title":"J Clin Oncol"},{"key":"175_CR8","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.canlet.2005.07.038","volume":"232","author":"A Lyakhovich","year":"2006","unstructured":"Lyakhovich A, Surralles J. Disruption of the Fanconi anemia\/BRCA pathway in sporadic cancer. Cancer Lett. 2006;232:99\u2013106.","journal-title":"Cancer Lett"},{"key":"175_CR9","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1038\/nrg2159","volume":"8","author":"W Wang","year":"2007","unstructured":"Wang W. Emergence of a DNA-damage response network consisting of Fanconi anaemia and BRCA proteins. Nat Rev Genet. 2007;8:735\u201348.","journal-title":"Nat Rev Genet"},{"key":"175_CR10","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/35076590","volume":"2","author":"H Joenje","year":"2001","unstructured":"Joenje H, Patel KJ. The emerging genetic and molecular basis of Fanconi anaemia. Nat Rev Genet. 2001;2:446\u201357.","journal-title":"Nat Rev Genet"},{"key":"175_CR11","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1093\/hmg\/9.18.2665","volume":"9","author":"JP Winter de","year":"2000","unstructured":"de Winter JP, van der Weel L, de Groot J, Stone S, Waisfisz Q, Arwert F, et al. The Fanconi anemia protein FANCF forms a nuclear complex with FANCA, FANCC and FANCG. Hum Mol Genet. 2000;9:2665\u201374.","journal-title":"Hum Mol Genet"},{"key":"175_CR12","doi-asserted-by":"crossref","first-page":"256","DOI":"10.4161\/cbt.5.3.2380","volume":"5","author":"Z Wang","year":"2006","unstructured":"Wang Z, Li M, Lu S, Zhang Y, Wang H. Promoter hypermethylation of FANCF plays an important role in the occurrence of ovarian cancer through disrupting Fanconi anemia-BRCA pathway. Cancer Biol Ther. 2006;5:256\u201360.","journal-title":"Cancer Biol Ther"},{"key":"175_CR13","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1038\/nm852","volume":"9","author":"T Taniguchi","year":"2003","unstructured":"Taniguchi T, Tischkowitz M, Ameziane N, Hodgson SV, Mathew CG, Joenje H, et al. Disruption of the Fanconi anemia-BRCA pathway in cisplatin-sensitive ovarian tumors. Nat Med. 2003;9:568\u201374.","journal-title":"Nat Med"},{"key":"175_CR14","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1038\/sj.onc.1207256","volume":"23","author":"CJ Marsit","year":"2004","unstructured":"Marsit CJ, Liu M, Nelson HH, Posner M, Suzuki M, Kelsey KT. Inactivation of the Fanconi anemia\/BRCA pathway in lung and oral cancers: implications for treatment and survival. Oncogene. 2004;23:1000\u20134.","journal-title":"Oncogene"},{"key":"175_CR15","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/j.1365-2141.2006.06107.x","volume":"134","author":"S Meyer","year":"2006","unstructured":"Meyer S, White DJ, Will AM, Eden T, Sim A, Brown R, et al. No evidence of significant silencing of Fanconi genes FANCF and FANCB or Nijmegen breakage syndrome gene NBS1 by DNA hyper-methylation in sporadic childhood leukaemia. Br J Haematol. 2006;134:61\u20133.","journal-title":"Br J Haematol"},{"key":"175_CR16","doi-asserted-by":"crossref","first-page":"2994","DOI":"10.1158\/0008-5472.CAN-04-0245","volume":"64","author":"G Narayan","year":"2004","unstructured":"Narayan G, Arias-Pulido H, Nandula SV, Basso K, Sugirtharaj DD, Vargas H, et al. Promoter hypermethylation of FANCF: disruption of Fanconi Anemia-BRCA pathway in cervical cancer. Cancer Res. 2004;64:2994\u20137.","journal-title":"Cancer Res"},{"key":"175_CR17","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1159\/000108297","volume":"118","author":"K Neveling","year":"2007","unstructured":"Neveling K, Kalb R, Florl AR, Herterich S, Friedl R, Hoehn H, et al. Disruption of the FA\/BRCA pathway in bladder cancer. Cytogenet Genome Res. 2007;118:166\u201376.","journal-title":"Cytogenet Genome Res"},{"key":"175_CR18","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s10549-007-9766-6","volume":"111","author":"M Wei","year":"2008","unstructured":"Wei M, Xu J, Dignam J, Nanda R, Sveen L, Fackenthal J, et al. Estrogen receptor alpha, BRCA1, and FANCF promoter methylation occur in distinct subsets of sporadic breast cancers. Breast Cancer Res Treat. 2008;111:113\u201320.","journal-title":"Breast Cancer Res Treat"},{"key":"175_CR19","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1038\/sj.bjc.6604325","volume":"98","author":"SL Lim","year":"2008","unstructured":"Lim SL, Smith P, Syed N, Coens C, Wong H, van der Burg M, et al. Promoter hypermethylation of FANCF and outcome in advanced ovarian cancer. Br J Cancer. 2008;98:1452\u20136.","journal-title":"Br J Cancer"},{"key":"175_CR20","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S1535-6108(03)00111-9","volume":"3","author":"OI Olopade","year":"2003","unstructured":"Olopade OI, Wei M. FANCF methylation contributes to chemoselectivity in ovarian cancer. Cancer Cell. 2003;3:417\u201320.","journal-title":"Cancer Cell"},{"key":"175_CR21","first-page":"1265","volume":"20","author":"K Kimura","year":"2008","unstructured":"Kimura K, Toyooka S, Tsukuda K, Yamamoto H, Suehisa H, Soh J, et al. The aberrant promoter methylation of BMP3b and BMP6 in malignant pleural mesotheliomas. Oncol Rep. 2008;20:1265\u20138.","journal-title":"Oncol Rep"},{"key":"175_CR22","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1476-4598-5-5","volume":"5","author":"F Hunter","year":"2006","unstructured":"Hunter F, Xie J, Trimble C, Bur M, Li KC. Rhodamine-RCA in vivo labeling guided laser capture microdissection of cancer functional angiogenic vessels in a murine squamous cell carcinoma mouse model. Mol Cancer. 2006;5:5.","journal-title":"Mol Cancer"},{"key":"175_CR23","doi-asserted-by":"crossref","unstructured":"Sun J, Chen Z, Zhu T, Yu J, Ma K, Zhang H, et al. Hypermethylated SFRP1, but none of other nine genes \u201cinformative\u201d for western countries, is valuable for bladder cancer detection in mainland China. J Cancer Res Clin Oncol. 2009 (in press).","DOI":"10.1007\/s00432-009-0619-z"},{"key":"175_CR24","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1002\/ijc.21358","volume":"118","author":"E Tokunaga","year":"2006","unstructured":"Tokunaga E, Kimura Y, Oki E, Ueda N, Futatsugi M, Mashino K, et al. Akt is frequently activated in HER2\/neu-positive breast cancers and associated with poor prognosis among hormone-treated patients. Int J Cancer. 2006;118:284\u20139.","journal-title":"Int J Cancer"},{"key":"175_CR25","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s10549-005-9112-9","volume":"97","author":"E Tokunaga","year":"2006","unstructured":"Tokunaga E, Oki E, Nishida K, Koga T, Yoshida R, Ikeda K, et al. Aberrant hypermethylation of the promoter region of the CHFR gene is rare in primary breast cancer. Breast Cancer Res Treat. 2006;97:199\u2013203.","journal-title":"Breast Cancer Res Treat"},{"key":"175_CR26","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1476-4598-3-33","volume":"3","author":"VS Dhillon","year":"2004","unstructured":"Dhillon VS, Shahid M, Husain SA. CpG methylation of the FHIT, FANCF, cyclin-D2, BRCA2 and RUNX3 genes in Granulosa cell tumors (GCTs) of ovarian origin. Mol Cancer. 2004;3:33.","journal-title":"Mol Cancer"}],"container-title":["Breast Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12282-009-0175-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12282-009-0175-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12282-009-0175-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,3]],"date-time":"2019-06-03T12:37:33Z","timestamp":1559565453000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12282-009-0175-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,10,8]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,4]]}},"alternative-id":["175"],"URL":"https:\/\/doi.org\/10.1007\/s12282-009-0175-z","relation":{},"ISSN":["1340-6868","1880-4233"],"issn-type":[{"value":"1340-6868","type":"print"},{"value":"1880-4233","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,10,8]]}}}